select a format

Single User License
USD 1500 INR 96435
Site License
USD 3000 INR 192870
Corporate User License
USD 4500 INR 289305

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Taiho Pharmaceutical Co., Ltd.-Product Pipeline Review-2015

Taiho Pharmaceutical Co., Ltd.-Product Pipeline Review-2015


  • Products Id :- GMDHC07523CDB
  • |
  • Pages: 52
  • |
  • August 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Taiho Pharmaceutical Co., Ltd.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Taiho Pharmaceutical Co., Ltd.-Product Pipeline Review-2015', provides an overview of the Taiho Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Taiho Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Taiho Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Taiho Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Taiho Pharmaceutical Co., Ltd.'s pipeline products

Reasons To Buy

Evaluate Taiho Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Taiho Pharmaceutical Co., Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Taiho Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Taiho Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Taiho Pharmaceutical Co., Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Taiho Pharmaceutical Co., Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 5

Taiho Pharmaceutical Co., Ltd. Snapshot 6

Taiho Pharmaceutical Co., Ltd. Overview 6

Key Information 6

Key Facts 6

Taiho Pharmaceutical Co., Ltd.-Research and Development Overview 7

Key Therapeutic Areas 7

Taiho Pharmaceutical Co., Ltd.-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Pipeline Products-Combination Treatment Modalities 12

Pipeline Products-Partnered Products 13

Partnered Products/Combination Treatment Modalities 14

Taiho Pharmaceutical Co., Ltd.-Pipeline Products Glance 15

Taiho Pharmaceutical Co., Ltd.-Late Stage Pipeline Products 15

Phase III Products/Combination Treatment Modalities 15

Taiho Pharmaceutical Co., Ltd.-Clinical Stage Pipeline Products 16

Phase I Products/Combination Treatment Modalities 16

Taiho Pharmaceutical Co., Ltd.-Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Discovery Products/Combination Treatment Modalities 18

Taiho Pharmaceutical Co., Ltd.-Drug Profiles 19

(tegafur + gimeracil + oteracil + calcium folinate) 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

(tegafur + gimeracil + oteracil) 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

bilastine 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

TAS-120 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

TAS-114 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

TAS-115 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

TAS-116 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

TAS-117 31

Product Description 31

Mechanism of Action 31

R&D Progress 31

TAS-119 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

TAS-121 34

Product Description 34

Mechanism of Action 34

R&D Progress 34

TAS-205 35

Product Description 35

Mechanism of Action 35

R&D Progress 35

TAS-2913 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

TAS-2985 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

TAS-5567 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Small Molecules to Inhibit S100B-p53 Interaction for Cancer 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

Taiho Pharmaceutical Co., Ltd.-Pipeline Analysis 40

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Target 40

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Route of Administration 41

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Molecule Type 42

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action 43

Taiho Pharmaceutical Co., Ltd.-Recent Pipeline Updates 44

Taiho Pharmaceutical Co., Ltd.-Dormant Projects 47

Taiho Pharmaceutical Co., Ltd.-Discontinued Pipeline Products 48

Discontinued Pipeline Product Profiles 48

(tegafur + gimeracil + oteracil) 48

orantinib 48

Taiho Pharmaceutical Co., Ltd.-Company Statement 49

Taiho Pharmaceutical Co., Ltd.-Locations And Subsidiaries 50

Head Office 50

Other Locations & Subsidiaries 50

Appendix 51

Methodology 51

Coverage 51

Secondary Research 51

Primary Research 51

Expert Panel Validation 51

Contact Us 51

Disclaimer 52

List of Tables

Taiho Pharmaceutical Co., Ltd., Key Information 6

Taiho Pharmaceutical Co., Ltd., Key Facts 6

Taiho Pharmaceutical Co., Ltd.-Pipeline by Indication, 2015 8

Taiho Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2015 10

Taiho Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2015 11

Taiho Pharmaceutical Co., Ltd.-Combination Treatment Modalities in Pipeline, 2015 12

Taiho Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2015 13

Taiho Pharmaceutical Co., Ltd.-Partnered Products/ Combination Treatment Modalities, 2015 14

Taiho Pharmaceutical Co., Ltd.-Phase III, 2015 15

Taiho Pharmaceutical Co., Ltd.-Phase I, 2015 16

Taiho Pharmaceutical Co., Ltd.-Preclinical, 2015 17

Taiho Pharmaceutical Co., Ltd.-Discovery, 2015 18

Taiho Pharmaceutical Co., Ltd.-Pipeline by Target, 2015 40

Taiho Pharmaceutical Co., Ltd.-Pipeline by Route of Administration, 2015 41

Taiho Pharmaceutical Co., Ltd.-Pipeline by Molecule Type, 2015 42

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Mechanism of Action, 2015 43

Taiho Pharmaceutical Co., Ltd.-Recent Pipeline Updates, 2015 44

Taiho Pharmaceutical Co., Ltd.-Dormant Developmental Projects,2015 47

Taiho Pharmaceutical Co., Ltd.-Discontinued Pipeline Products, 2015 48

Taiho Pharmaceutical Co., Ltd., Subsidiaries 50

List of Figures

Taiho Pharmaceutical Co., Ltd.-Pipeline by Top 10 Indication, 2015 8

Taiho Pharmaceutical Co., Ltd.-Pipeline by Stage of Development, 2015 10

Taiho Pharmaceutical Co., Ltd.-Monotherapy Products in Pipeline, 2015 11

Taiho Pharmaceutical Co., Ltd.-Partnered Products in Pipeline, 2015 13

Taiho Pharmaceutical Co., Ltd.-Pipeline by Top 10 Target, 2015 40

Taiho Pharmaceutical Co., Ltd.-Pipeline by Top 10 Route of Administration, 2015 41

Taiho Pharmaceutical Co., Ltd.-Pipeline by Top 10 Molecule Type, 2015 42

Taiho Pharmaceutical Co., Ltd.-Pipeline Products by Top 10 Mechanism of Action, 2015 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Taiho Pharmaceutical Co., Ltd.; Taiho Pharmaceutical Co., Ltd. - Key Therapeutics; Taiho Pharmaceutical Co., Ltd. - Pipeline Overview and Promising Molecules; Taiho Pharmaceutical Co., Ltd. - News; Taiho Pharmaceutical Co., Ltd. - Latest Updates; Taiho Pharmaceutical Co., Ltd. - Pipeline; Taiho Pharmaceutical Co., Ltd. - Discontinued/Dormant Projects


Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com